0001569052-25-000002.txt : 20250905 0001569052-25-000002.hdr.sgml : 20250905 20250904174322 ACCESSION NUMBER: 0001569052-25-000002 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: Rule 506(b) provides a "safer harbor" for a private offering FILED AS OF DATE: 20250905 DATE AS OF CHANGE: 20250904 EFFECTIVENESS DATE: 20250905 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Angiocrine Bioscience, Inc. CENTRAL INDEX KEY: 0001569052 ORGANIZATION NAME: EIN: 460855286 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-556712 FILM NUMBER: 251294452 BUSINESS ADDRESS: STREET 1: 11575 SORRENTO VALLEY RD, STE 217 CITY: SAN DIEGO STATE: CA ZIP: 92121 BUSINESS PHONE: 858-436-8047 MAIL ADDRESS: STREET 1: 11575 SORRENTO VALLEY RD, STE 217 CITY: SAN DIEGO STATE: CA ZIP: 92121 D 1 primary_doc.xml X0708 D LIVE 0001569052 Angiocrine Bioscience, Inc. 11585 SORRENTO VALLEY RD, STE 109 SAN DIEGO CA CALIFORNIA 92121 858-436-8047 DELAWARE None None Corporation true Paul W Finnegan 11585 Sorrento Valley Rd Ste 109 San Diego CA CALIFORNIA 92121 Executive Officer Director President/Chief Executive Officer Jeffrey L Port 11585 Sorrento Valley Rd Ste 109 San Diego CA CALIFORNIA 92121 Director David Parkinson 11585 Sorrento Valley Rd Ste 109 San Diego CA CALIFORNIA 92121 Director John T Lomoro 11585 Sorrento Valley Rd Ste 109 San Diego CA CALIFORNIA 92121 Executive Officer Chief Financial Officer/Treasurer John R Jaskowiak 11585 Sorrento Valley Rd Ste 109 San Diego CA CALIFORNIA 92121 Executive Officer Chief Operating Officer/Secretary Biotechnology Decline to Disclose 06b false 2025-08-21 false true false 0 3000000 2100000 900000 false 16 0 0 0 false Angiocrine Bioscience, Inc. Paul W. Finnegan, M.D. Paul W. Finnegan, M.D. President and CEO 2025-09-04